UOC
UBS O'Connor Portfolio holdings
AUM
$1.93B
1-Year Return
38.75%
This Quarter Return
+3.8%
1 Year Return
+38.75%
3 Year Return
+182.42%
5 Year Return
+480.25%
10 Year Return
+1,573.29%
AUM
$3.77B
AUM Growth
-$242M
(-6%)
Cap. Flow
-$294M
Cap. Flow
% of AUM
-7.81%
Top 10 Holdings %
Top 10 Hldgs %
58.56%
Holding
566
New
99
Increased
122
Reduced
58
Closed
164
Top Buys
Top Sells
| 1 |
CTLT
CATALENT, INC.
CTLT
|
$234M |
| 2 |
MRO
Marathon Oil Corporation
MRO
|
$222M |
| 3 |
SRCL
Stericycle Inc
SRCL
|
$172M |
| 4 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
$150M |
| 5 |
PRFT
Perficient Inc
PRFT
|
$79.6M |
Sector Composition
| 1 | Technology | 30.66% |
| 2 | Energy | 16.79% |
| 3 | Financials | 8.26% |
| 4 | Consumer Staples | 8.25% |
| 5 | Materials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Perspective Therapeutics
CATX
$257M
| $393K | 0.01% |
123,243
+52,320
| +74% | +$167K |
|
|
CRGX
277
DELISTED
CARGO Therapeutics
CRGX
| $388K | 0.01% |
26,899
+4,851
| +22% | +$70K |
|
278
argenx
ARGX
$45.9B
| $375K | 0.01% |
610
-1,390
| -70% | -$855K |
|
279
CG Oncology
CGON
$2.52B
| $368K | 0.01% |
12,834
+1,810
| +16% | +$51.9K |
|
280
Soleno Therapeutics
SLNO
$3.71B
| $359K | 0.01% |
7,977
-7,559
| -49% | -$340K |
|
281
Mineralys Therapeutics
MLYS
$2.31B
| $346K | 0.01% |
28,068
-3,000
| -10% | -$36.9K |
|
282
Context Therapeutics
CNTX
$73.6M
| $324K | 0.01% |
308,758
| – | – |
|
283
Super Micro Computer
SMCI
$24B
| $305K | 0.01% |
+10,000
| New | +$305K |
|
284
AMC Entertainment Holdings
AMC
$1.41B
| $302K | 0.01% |
75,994
-1,034
| -1% | -$4.12K |
|
285
Leap Therapeutics
LPTX
$11.7M
| $302K | 0.01% |
105,108
-60,000
| -36% | -$173K |
|
286
Dyne Therapeutics
DYN
$2.02B
| $296K | 0.01% |
12,584
-6,734
| -35% | -$159K |
|
287
Alkermes
ALKS
$4.94B
| $279K | 0.01% |
9,710
-40,251
| -81% | -$1.16M |
|
|
SEPN
288
Septerna, Inc. Common Stock
SEPN
$643M
| $278K | 0.01% |
+12,118
| New | +$278K |
|
289
Palo Alto Networks
PANW
$130B
| $257K | 0.01% |
+1,412
| New | +$257K |
|
290
Ardelyx
ARDX
$1.57B
| $252K | 0.01% |
49,701
-11,035
| -18% | -$55.9K |
|
291
LendingClub
LC
$1.9B
| $243K | 0.01% |
+15,000
| New | +$243K |
|
292
Fortinet
FTNT
$60.4B
| $240K | 0.01% |
+2,537
| New | +$240K |
|
293
Minerva Neurosciences
NERV
$16.4M
| $238K | 0.01% |
107,256
| – | – |
|
294
Intuit
INTU
$188B
| $237K | 0.01% |
+377
| New | +$237K |
|
295
SCYNEXIS
SCYX
$37.3M
| $236K | 0.01% |
195,393
+35,233
| +22% | +$42.6K |
|
296
ZTO Express
ZTO
$14.7B
| $231K | 0.01% |
+11,800
| New | +$231K |
|
297
Pyxis Oncology
PYXS
$118M
| $228K | 0.01% |
+146,400
| New | +$228K |
|
298
Black Diamond Therapeutics
BDTX
$167M
| $224K | 0.01% |
104,560
+13,854
| +15% | +$29.6K |
|
299
Veru
VERU
$49.4M
| $215K | 0.01% |
32,986
| – | – |
|
300
Corvus Pharmaceuticals
CRVS
$459M
| $214K | 0.01% |
+40,000
| New | +$214K |
|